Health TrialsbyHealthPanel

Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)

ConditionFetal Growth Retardation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorShanghai First Maternity and Infant Hospital

About this trial

This study intends to prospectively enroll high-risk pregnant women to establish a multicenter cohort. By combining maternal basic characteristics, medical history, early pregnancy ultrasound, and biological markers, we aim to construct a joint predictive model for MVM-FGR.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women with gestational age of <14 weeks

Maternal age between 18 and 45 years old

Maternal age >40 years

Nulliparous, Maternal age >38 years

Disqualifiers

Presence of fetal genetic abnormalities or severe structural abnormalities in prenatal ultrasound or genetic testing.

Trial population

First trimester pregnancy women who are at higher risk of fetal growth restriction.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Present of maternal-vascular-malperfusion (MVM)-FGR

Development of MVM Fetal growth restriction

Time frame
during the pregnancy, up to an average gestational age of 40 weeks

Secondary outcomes

1

Other adverse pregnancy outcome

including miscarriage, preeclampsia; intrauterine fetal death

Time frame
pregnancy-born after 28 days
2

GA at delivery, birth weight, neonatal outcomes.

GA at delivery, birth weight, neonatal outcomes.

Time frame
the day at birth

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shanghai First Maternity and Infant Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now